BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29306018)

  • 1. Aldehyde dehydrogenase 1A3 (ALDH1A3) is regulated by autophagy in human glioblastoma cells.
    Wu W; Schecker J; Würstle S; Schneider F; Schönfelder M; Schlegel J
    Cancer Lett; 2018 Mar; 417():112-123. PubMed ID: 29306018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
    Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
    Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
    Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
    Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.
    Le Calvé B; Rynkowski M; Le Mercier M; Bruyère C; Lonez C; Gras T; Haibe-Kains B; Bontempi G; Decaestecker C; Ruysschaert JM; Kiss R; Lefranc F
    Neoplasia; 2010 Sep; 12(9):727-39. PubMed ID: 20824049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
    Tian T; Mingyi M; Qiu X; Qiu Y
    Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.
    Fan TY; Wang H; Xiang P; Liu YW; Li HZ; Lei BX; Yu M; Qi ST
    Int J Clin Exp Pathol; 2014; 7(10):6662-70. PubMed ID: 25400745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.
    Cheng Q; Ma X; Cao H; Chen Z; Wan X; Chen R; Peng R; Huang J; Jiang B
    Mol Med Rep; 2017 Feb; 15(2):597-604. PubMed ID: 28035389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
    Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
    Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
    Huang S; Qi P; Zhang T; Li F; He X
    Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma.
    Li G; Li Y; Liu X; Wang Z; Zhang C; Wu F; Jiang H; Zhang W; Bao Z; Wang Y; Cai J; Zhao L; Kahlert UD; Jiang T; Zhang W
    Cell Death Dis; 2018 Dec; 9(12):1190. PubMed ID: 30538217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
    Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
    J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of ALDH1A3 promoter methylation in gliob;astoma: a single center experience in Western China.
    Ni W; Luo L; Ping Z; Yuan HP; Zhao XD; Xu W
    Asian Pac J Cancer Prev; 2015; 16(2):591-4. PubMed ID: 25684492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.
    Jaime-Ramirez AC; Dmitrieva N; Yoo JY; Banasavadi-Siddegowda Y; Zhang J; Relation T; Bolyard C; Wojton J; Kaur B
    J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28087981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2.
    Qi XC; Xie DJ; Yan QF; Wang YR; Zhu YX; Qian C; Yang SX
    Biochem Biophys Res Commun; 2013 Aug; 437(4):565-72. PubMed ID: 23850692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma.
    Wu W; Wu Y; Mayer K; von Rosenstiel C; Schecker J; Baur S; Würstle S; Liesche-Starnecker F; Gempt J; Schlegel J
    Transl Oncol; 2020 Mar; 13(3):100748. PubMed ID: 32087559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems.
    Toren A; Pismenyuk T; Yalon M; Freedman S; Simon AJ; Fisher T; Moshe I; Reichardt JK; Constantini S; Mardor Y; Last D; Guez D; Daniels D; Assoulin M; Mehrian-Shai R
    Oncotarget; 2016 Nov; 7(46):74860-74871. PubMed ID: 27556862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines.
    Liu Y; Xu N; Liu B; Huang Y; Zeng H; Yang Z; He Z; Guo H
    Oncotarget; 2016 Jul; 7(28):43835-43851. PubMed ID: 27270310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Sensitivity to ALDH1A3-Dependent Ferroptosis in TMZ-Resistant Glioblastoma Cells.
    Wu Y; Franzmeier S; Liesche-Starnecker F; Schlegel J
    Cells; 2023 Oct; 12(21):. PubMed ID: 37947601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the molecular mechanisms of acquired temozolomide resistance in the U251 glioblastoma cell line by protein microarray.
    Lin J; Zuo J; Cui Y; Song C; Wu X; Feng H; Li J; Li S; Xu Q; Wei W; Qiu G; He H
    Oncol Rep; 2018 May; 39(5):2333-2341. PubMed ID: 29565460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.